Clinical features of acute myocardial infarction in elderly patients

Acta Medica Okayama

Volumn 65, Issue 6, 2011, Pages 379-386

  Shiraki, Teruo ^a   Saito, Daiji ^a  

^a IWAKUNI NATIONAL HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Coronary risk factor; Elderly

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 84858256146     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N Engl J Med (1985) 312: 932-936.
2. Rentrop KP, Cohen M, Blanke H and Phillip RA: Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol (1985)5: 587-592.
3. Goch A, Misiewicz P, Rysz J and Banach M: The clinical manifestation of myocardial infarction in elderly patients. Clin Cardiol (2009)6: E46-51.
4. Zimmermann S, Ruthrof S, Nowak K, Klinghammer L, Ludwig J, Daniel WG and Flachskampf FA Outcomes of contemporary interventional therapy of ST elevation infarction in patients older than 75 years. Clin Cardiol (2009) 32: 87-93.
5. Sconenberger AW, Radovanovic D, Stauffer JC, Windecker S, Urban P, Niedermaier G, Keller PF, Gutzwiller F, Erne P and For the AMIS Plus Investigators: Acute coronary syndromes in young patients: Presentation, treatment and outcome. Int J Cardiol (2011) 148: 300-304.
6. Health and welfare statistics association: Dyslipidemia; in Journal of health and welfare statistics, Health and welfare statistics association, Tokyo (2010) pp 80-81
7. Wenaweser P, Ramser M, Windecker S, Lutolf I, Meier B, Seiler C, Eberli FR and Hess OM Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2007) 70: 485-490.
8. de Labriolle A, Giaudeau B, Pacouret G, Deveaux B, Quilliet L, Charbonnier B and Fauchier L Revascularization algorithm in acute STEM I should take into account age. Cadiovasc Revasc Med (2007) 8: 90-93.
9. Kawamura A, Lombardi DA, Tilem ME, Gossman DE, Plemonte TC and Nesto RW Stroke complicating percutaneous coronary intervention in patients with acute myocardial infarction. Circ J (2007) 71: 1370-1375.
10. Jaffe R, Hong T, Sharieff W, Chisholm RJ, Kutryk M, Charron T and Cheema AN Comaparison of radial versus femoral approach for percutaneous coronary intervention in octogenarians. Catheter Cardiovasc Interv (2007) 69: 815-820.
11. McCullough PA, Soman SS, Smith ST, markes KR, Yee J and Borzak S Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol (2000) 36: 679-684.
12. Mielniczuk LM, Pfeiffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, Mohanavelu S, Callif RM and Braunwald E Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J (2008) 155: 725-731.
13. Oldgren J, Wallentin L, Grip L, Linder Norgaard bL and Siegban A Myocardial damage, inflammation and thrmobin inhibition in unstable coronary artery disease: Eur Heart J (2003) 24: 86-93
14. Tonelli M, Sacks F, Pfeiffer M, Gao Z, Curthan G, for the Cholesterol and Recurrent Events (CARE) Trial Investigators: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 112: 2627-2633.
15. Goodman WG, London G and Vascular Calcification Work Group: Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004)43: 572-579.
16. Feinberg WM, Blackshear JL, Laupacis A, Kronal R and Hart RG: Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 155: 469-473.
17. Takahashi N, Ishibashi Y, ShimadaT, Sakane T, OhtaY, Inoue S, Nakamura K, Shiomizu H, Katoh H and Murakami Y Impaired exercise-induced vasodilation in chronic atrial fibrillation. Circ J (2002)66: 583-588.
18. Nakamura H, Arakawa K, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y for the MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): a prospective randomized controlled trial. Lancet (2006) 368: 1155-1163.
19. Maroo BP, Lavie CJ and Milani RV Secondary prevention of coronary heart disease in elderly patients following myocardial infarction. Drug Aging (2008) 25: 649-664.
20. Bemmel T, GusseklooJ, Westendrop R and Blauw GJ In a population-based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens (2006) 24: 287-292.
21. Ridker PM, Danielson E, Fonseco F, Genest J, Gotto AM, Kastelein J, Koenig W, Libby P, Loerenzatti AJ, MacFadyen JG, Nordestgaar BG, Shepherd J, Willerson JT, Glynn RJ for the JUPITER Study Group: Rouvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008)359: 2195-2207.
22. Bardran HM, Elnoamany MF, Khalil TS and Eldin MME Age-related alteration of risk profile, inflammatory response, and angiographic findings in patients with acute coronary syndrome. Clin Med Cardiol (2009) 3: 15-28.